Non-injection and injection drug use and STI/HIV risk in the United States: The degree to which sexual risk behaviors versus sex with an STI-infected partner account for infection transmission among drug users

AIDS and Behavior

Volumn 17, Issue 3, 2013, Pages 1185-1194

  Khan, Maria R ^a   Berger, Amanda ^b   Hemberg, Jordana ^c   O'Neill, Allison ^c   Dyer, Typhanye Penniman ^a   Smyrk, Kristina ^c  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b Child Trends ^*  (United States)

^c UNIVERSITY OF MARYLAND   (United States)

Author keywords

Drug use; HIV; IDU; Sexual risk behavior; Sexually transmitted infection; United States

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CONDOM; DISEASE TRANSMISSION; DRUG USE; FEMALE; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; RISK FACTOR; SEXUAL BEHAVIOR; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; STATISTICS; SUBSTANCE ABUSE; UNITED STATES; UTILIZATION REVIEW;

ADOLESCENT; ADULT; CONDOMS; DRUG USERS; FEMALE; HIV INFECTIONS; HUMANS; MALE; RISK FACTORS; RISK-TAKING; SEXUAL BEHAVIOR; SEXUAL PARTNERS; SEXUALLY TRANSMITTED DISEASES; SUBSTANCE ABUSE, INTRAVENOUS; UNITED STATES; YOUNG ADULT;

EID: 84880791749     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-012-0276-0     Document Type: Article

References (51)

1. CDC. Trends in Sexually Transmitted Diseases in the United States: 2009 National Data for Gonorrhea, Chlamydia and Syphilis Atlanta, GA: Centers for Disease Control and Prevention (CDC), U.S. Department of Health and Human Services, 2009.
2. CDC. HIV Surveillance Report: Diagnoses of HIV infection and AIDS in the United States and Dependent Areas, 2009. Available at: http://www.cdc.gov/hiv/ surveillance/resources/reports/2009report/.
3. Celentano DD, Latimore AD, Mehta SH. Variations in sexual risks in drug users: emerging themes in a behavioral context. Curr HIV/AIDS Rep. 2008;5(4):212-8.
4. Ross MW, Williams ML. Sexual behavior and illicit drug use. Annu Rev Sex Res. 2001;12:290-310. (Pubitemid 41755069)
5. Hwang LY, Ross MW, Zack C, Bull L, Rickman K, Holleman M. Prevalence of sexually transmitted infections and associated risk factors among populations of drug abusers. Clin Infect Dis. 2000;31(4):920-6. (Pubitemid 32299348)
6. Booth RE, Kwiatkowski CF, Chitwood DD. Sex related HIV risk behaviors: differential risks among injection drug users, crack smokers, and injection drug users who smoke crack. Drug Alcohol Depend. 2000;58(3):219-26. (Pubitemid 30079672)
7. McCoy CB, Lai S, Metsch LR, Messiah SE, Zhao W. Injection drug use and crack cocaine smoking: independent and dual risk behaviors for HIV infection. Ann Epidemiol. 2004;14(8):535-42. (Pubitemid 39221231)
8. Lejuez CW, Bornovalova MA, Daughters SB, Curtin JJ. Differences in impulsivity and sexual risk behavior among inner-city crack-cocaine users and heroin users. Drug Alcohol Depend. 2005;77(2):169-75. (Pubitemid 40128195)
9. Khan MR, Bolyard M, Sandoval M, et al. Social and behavioral correlates of sexually transmitted infection- and HIV-discordant sexual partnerships in Bushwick, Brooklyn, New York. J Acquir Immune Defic Syndr. 2009;51(4):470-85.
10. Friedman SR, Flom PL, Kottiri BJ, et al. Drug use patterns and infection with sexually transmissible agents among young adults in a high-risk neighbourhood in New York City. Addiction. 2003;98(2):159-69. (Pubitemid 36140367)
11. Sena AC, Muth SQ, Heffelfinger JD, O'Dowd JO, Foust E, Leone P. Factors and the sociosexual network associated with a syphilis outbreak in rural North Carolina. Sex Transm Dis. 2007;34(5):280-7. (Pubitemid 46707480)
12. Ellen JM, Langer LM, Zimmerman RS, Cabral RJ, Fichtner R. The link between the use of crack cocaine and the sexually transmitted diseases of a clinic population. A comparison of adolescents with adults. Sex Transm Dis. 1996;23(6):511-6. (Pubitemid 26391577)
13. Adimora AA, Schoenbach VJ, Martinson FE, et al. Heterosexually transmitted HIV infection among African Americans in North Carolina. J Acquir Immune Defic Syndr. 2006;41(5):616-23.
14. Miller M, Liao Y, Wagner M, Korves C. HIV, the clustering of sexually transmitted infections, and sex risk among African American women who use drugs. Sex Transm Dis. 2008;35(7):696-702.
15. Plitt SS, Sherman SG, Strathdee SA, Taha TE. Herpes simplex virus 2 and syphilis among young drug users in Baltimore, Maryland. Sex Transm Infect. 2005;81(3):248-53. (Pubitemid 40835054)
16. Des Jarlais DC, Arasteh K, McKnight C, Hagan H, Perlman D, Friedman SR. Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City. Drug Alcohol Depend. 2009;101(1-2):88-91.
17. Strathdee SA, Sherman SG. The role of sexual transmission of HIV infection among injection and non-injection drug users. J Urban Health. 2003;80(4 Suppl 3):iii7-14.
18. Kral AH, Bluthenthal RN, Lorvick J, Gee L, Bacchetti P, Edlin BR. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet. 2001;357(9266):1397-401. (Pubitemid 32455367)
19. Lindenburg CE, Krol A, Smit C, Buster MC, Coutinho RA, Prins M. Decline in HIV incidence and injecting, but not in sexual risk behaviour, seen in drug users in Amsterdam: a 19-year prospective cohort study. AIDS. 2006;20(13):1771-5. (Pubitemid 44299369)
20. CDC. STD Health Equity. 2011. http://www.cdc.gov/std/health-disparities/ default.htm. Accessed 28 February 2011.
21. SAMHSA. Results from the 2009 national survey on drug use and health: volume I. Summary of national findings. Rockville, MD: Office of Applied Studies, SAMHSA, 2010.
22. SAMHSA. The NSDUH report: injection drug use. Rockville, MD: Office of Applied Studies, SAMHSA, 2003.
23. Weinstock H, Berman S, Cates W Jr. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health. 2004;36(1):6-10. (Pubitemid 38258322)
24. CDC. Trends in reportable sexually transmitted diseases in the United States, 2006: National Surveillance Data for Chlamydia, Gonorrhea, and Syphilis, 2007.
25. Nusbaum MR, Wallace RR, Slatt LM, Kondrad EC. Sexually transmitted infections and increased risk of co-infection with human immunodeficiency virus. J Am Osteopath Assoc. 2004;104(12):527-35. (Pubitemid 40543140)
26. Westrom L, Eschenbach D. Pelvic inflammatory disease. In: Holmes KK, Sparling PF, Mårdh P, editors. Sexually transmitted diseases, 3rd edn. New York: McGraw-Hill; pp. 783-809.
27. Schulz KF, Cates W Jr, O'Mara PR. Pregnancy loss, infant death, and suffering: legacy of syphilis and gonorrhoea in Africa. Genitourin Med. 1987;63(5):320-5. (Pubitemid 17152592)
28. Gust DA, Levine WC, St Louis ME, Braxton J, Berman SM. Mortality associated with congenital syphilis in the United States, 1992-1998. Pediatrics. 2002;109(5):E79-89.
29. Marai W. Lower genital tract infections among pregnant women: a review. East Afr Med J. 2001;78(11):581-5. (Pubitemid 33395858)
30. Cohen MS. HIV and sexually transmitted diseases: lethal synergy. Top HIV Med. 2004;12(4):104-7.
31. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect. 1999;75(1):3-17. (Pubitemid 29117474)
32. Cohen MS. Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis. Lancet. 1998;351(Suppl 3):5-7. (Pubitemid 128643728)
33. Wasserheit JN. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Trans Dis. 1992;19(2):61-77. (Pubitemid 23101885)
34. Cohen MS, Hoffman IF, Royce RA, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet. 1997;349(9069):1868-73. (Pubitemid 27270120)
35. Bearman PS, Jones J, Udry JR. The national longitudinal study of adolescent health. Carolina Population Center, The University of North Carolina at Chapel Hill. Available at: http://www.cpc.unc.edu/projects/addhealth. Accessed August 2, 2012.
36. Udry JR. References, instruments, and questionnaires consulted in the development of the add health in-home adolescent interview. Carolina Population Center, The University of North Carolina at Chapel Hill. Available at: http://www.cpc.unc.edu/projects/addhealth/data/guides/refer.pdf. Accessed August 2, 2012.
37. Resnick MD, Bearman PS, Blum RW, et al. Protecting adolescents from harm. Findings from the National Longitudinal Study on Adolescent Health. JAMA. 1997;278(10):823-32. (Pubitemid 27383372)
38. Chantala K, Tabor J. Strategies to perform a design-based analysis using the add health data. Carolina Population Center, The University of North Carolina at Chapel Hill. Available at: http://www.cpc.unc.edu/projects/ addhealth/data/guides/weight1.pdf. Accessed August 2, 2012.
39. Sieving RE, Beuhring T, Resnick MD, et al. Development of adolescent self-report measures from the National Longitudinal Study of Adolescent Health. J Adolesc Health. 2001;28(1):73-81. (Pubitemid 32014399)
40. Cohen M, Feng Q, Ford CA, et al. Biomarkers in wave III of the add health study. Carolina Population Center, The University of North Carolina at Chapel Hill. Available at: http://www.cpc.unc.edu/projects/addhealth/faqs/aboutdata/ index.html/biomark.pdf. Accessed August 2, 2012.
41. Watson EJ, Templeton A, Russell I, et al. The accuracy and efficacy of screening tests for Chlamydia trachomatis: a systematic review. J Med Microbiol. 2002;51(12):1021-31. (Pubitemid 36020722)
42. Johnson RE, Green TA, Schachter J, et al. Evaluation of nucleic acid amplification tests as reference tests for Chlamydia trachomatis infections in asymptomatic men. J Clin Microbiol. 2000;38(12):4382-6. (Pubitemid 32244522)
43. Koumans EH, Johnson RE, Knapp JS, St Louis ME. Laboratory testing for Neisseria gonorrhoeae by recently introduced nonculture tests: a performance review with clinical and public health considerations. Clin Infect Dis. 1998;27(5):1171-80.
44. McNutt LA, Wu C, Xue X, Hafner JP. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol. 2003;157(10):940-3. (Pubitemid 36555054)
45. Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702-6. (Pubitemid 38405384)
46. Friedman SR, Bolyard M, Maslow C, Mateu-Gelabert P, Sandoval M. Harnessing the power of social networks to reduce HIV risk. Focus. 2005;20(1):5-6.
47. Darke S, Kaye S, McKetin R, Duflou J. Major physical and psychological harms of methamphetamine use. Drug Alcohol Rev. 2008;27(3):253-62.
48. Gonzales R, Mooney L, Rawson RA. The methamphetamine problem in the United States. Annu Rev Public Health. 31:385-398.
49. Shrem MT, Halkitis PN. Methamphetamine abuse in the United States: contextual, psychological and sociological considerations. J Health Psychol. 2008;13(5):669-79. (Pubitemid 351758649)
50. Molitor F, Truax SR, Ruiz JD, Sun RK. Association of methamphetamine use during sex with risky sexual behaviors and HIV infection among non-injection drug users. West J Med. 1998;168(2):93-7. (Pubitemid 28100967)
51. Molitor F, Bell RA, Truax SR, Ruiz JD, Sun RK. Predictors of failure to return for HIV test result and counseling by test site type. AIDS Educ Prev. 1999;11(1):1-13. (Pubitemid 29110364)